Africa’s Aspin jumps after Reuters reports Glaxo interest

Shares in Aspin, Africa’s biggest drugmaker, jumped as much as 12 percent on March 25 after a Reuters report that GlaxoSmithKline planned to buy a stake in the firm. People familiar with the situation said the move, which could be announced very soon, was designed to strengthen Glaxo’s partnership with the South African drugmaker and boost its position in emerging markets. Bloomberg picked up the story with a Reuters credit, as did a number of other online media outlets, including MarketWatch, Forbes and S&P.